MedTrace Logo

Clinical Efficacy and Safety of Loxacon Dietary Supplement Capsules at Patients With Knee Arthrosis

NCT05925725 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-11-15

No results posted yet for this study

Summary

The study will be a multicenter, randomized, double-blind, follow-up clinical trial.

Neither the examining doctor nor the patient knows which capsule they will receive. Just the test unlock the codes after completion. T

Conditions

  • Osteo Arthritis Knee

Interventions

DRUG

• harpagozid • boswellin = LOXACON

Exercise therapy

Sponsors & Collaborators

  • Polyclinic of the Hospitaller Brothers of St. John of God, Budapest

    lead OTHER

Principal Investigators

  • Zoltán Dégi, M.D · Goodwill Pharma

  • Zoltán Dégi · Goodwill Pharma

  • Tamas Bender · Polyclinic of the Hospitaller Brothers of St. John of God, Budapest

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-25
Primary Completion
2023-05-05
Completion
2023-09-06

Countries

  • Hungary

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05925725 on ClinicalTrials.gov